UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function

International journal of clinical practice (Esher), 2008-07, Vol.62 (7), p.1087-1095

2008

Volltextzugriff (PDF)

Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes

International journal of clinical practice (Esher), 2008-08, Vol.62 (8), p.1279-1284

2008

Volltextzugriff (PDF)

Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis

International journal of clinical practice (Esher), 2010-06, Vol.64 (7), p.984-990

2010

Volltextzugriff (PDF)

Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk

Diabetes, obesity & metabolism, 2012-12, Vol.14 (12), p.1123-1128

2012

Volltextzugriff (PDF)

Structure of proof of concept studies that precede a nonalcoholic steatohepatitis development program

Clinical pharmacology and therapeutics, 2017-04, Vol.101 (4), p.444-446

2017

Volltextzugriff (PDF)

Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function

Diabetes, obesity & metabolism, 2013-12, Vol.15 (12), p.1101-1110

2013

Volltextzugriff (PDF)

Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes

International journal of clinical practice (Esher), 2011-09, Vol.65 (9), p.930-938

2011

Volltextzugriff (PDF)

Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2010-05, Vol.12 (5), p.442-451

2010

Volltextzugriff (PDF)

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial

Diabetes, obesity & metabolism, 2011-02, Vol.13 (2), p.160-168

2011

Volltextzugriff (PDF)

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2010-03, Vol.12 (3), p.252-261

2010

Volltextzugriff (PDF)

Human epicardial adipose tissue is a source of inflammatory mediators

Circulation (New York, N.Y.), 2003-11, Vol.108 (20), p.2460-2466

2003

Volltextzugriff (PDF)

Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study

Current medical research and opinion, 2005-12, Vol.21 (12), p.2029-2035

2005

Volltextzugriff (PDF)

Metabolic effects of vanadyl sulfate in humans with non—insulin-dependent diabetes mellitus: In vivo and in vitro studies

Metabolism, clinical and experimental, 2000-03, Vol.49 (3), p.400-410

2000

Volltextzugriff (PDF)

Regenerative Proliferation in Inner Ear Sensory Epithelia from Adult Guinea Pigs and Humans

Science (American Association for the Advancement of Science), 1993-03, Vol.259 (5101), p.1619-1622

1993

Volltextzugriff (PDF)

The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus

Diabetes, obesity & metabolism, 2011-07, Vol.13 (7), p.644-652

2011

Volltextzugriff (PDF)

Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis

Diabetes (New York, N.Y.), 1998-03, Vol.47 (3), p.493-497

1998

Volltextzugriff (PDF)

Insulin-stimulated Hydrogen Peroxide Reversibly Inhibits Protein-tyrosine Phosphatase 1B in Vivo and Enhances the Early Insulin Action Cascade

The Journal of biological chemistry, 2001-06, Vol.276 (24), p.21938-21942

2001

Volltextzugriff (PDF)

Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone-a factorial study

Diabetes, obesity & metabolism, 2014-03, Vol.16 (3), p.223-230

2014

Volltextzugriff (PDF)

Closing the gap between clinical research and clinical practice: can outcome studies with thiazolidinediones improve our understanding of type 2 diabetes?

International journal of clinical practice (Esher), 2006-07, Vol.60 (7), p.873-883

GOLDSTEIN, B. J.

2006

Volltextzugriff (PDF)

Sitagliptin improves glycaemic excursion after a meal or after an oral glucose load in Japanese subjects with impaired glucose tolerance

Diabetes, obesity & metabolism, 2015-11, Vol.17 (11), p.1033-1041

2015

Volltextzugriff (PDF)

Effect of initial combination therapy with sitagliptin and metformin on β-cell function in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2012-01, Vol.14 (1), p.67-76

2012

Volltextzugriff (PDF)

Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2012-05, Vol.14 (5), p.409-418

2012

Volltextzugriff (PDF)

A comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitus

International journal of clinical practice (Esher), 2015-06, Vol.69 (6), p.626-631

2015

Volltextzugriff (PDF)

Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes

American journal of physiology: endocrinology and metabolism, 1995-05, Vol.268 (5), p.E932-E940

1995

Volltextzugriff (PDF)

A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents

Diabetes, obesity & metabolism, 2011-09, Vol.13 (9), p.841-849

2011

Volltextzugriff (PDF)

1 – 25 von 6.481

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.701)
Mit Volltextzugriff
(5.001)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(4.138)
Life Sciences & Biomedicine
(3.280)
Humans
(2.875)
Male
(1.684)
Female
(1.654)
Biological And Medical Sciences
(1.429)
Medical Sciences
(1.202)
Adult
(1.067)
Middle Aged
(1.012)
Animals
(780)
Physical Sciences
(719)
Aged
(686)
Neurosciences & Neurology
(470)
Adolescent
(394)
Clinical Neurology
(325)
Risk Factors
(318)
Physics
(315)
Cardiovascular System & Cardiology
(314)
Technology
(310)
Fundamental And Applied Biological Sciences. Psychology
(292)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(3.515)
EZB Electronic Journals Library
(2.764)
Ingenta
(2.707)
Journals@Ovid Full Text
(2.603)
Publisher or Other Site
(1.766)
Elsevier ScienceDirect Journals Complete
(1.548)
IngentaConnect Journals
(1.160)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.053)
Wiley Online Library
(1.013)
Wiley Online Library Full Collection 2018
(704)
Oxford Journals
(312)
JSTOR
(311)
Springer Online Journals
(283)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(198)
Nature
(185)
Oxford Journals 2020 Medicine
(181)
Psychology and Behavioral Sciences Collection
(142)
IEEE Xplore
(135)
Taylor & Francis Journals
(125)
Taylor & Francis Online
(122)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(19)
... seit 30 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function

Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes

Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis

Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk

Structure of proof of concept studies that precede a nonalcoholic steatohepatitis development program

Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function

Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes

Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

Human epicardial adipose tissue is a source of inflammatory mediators

Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study

Metabolic effects of vanadyl sulfate in humans with non—insulin-dependent diabetes mellitus: In vivo and in vitro studies

Regenerative Proliferation in Inner Ear Sensory Epithelia from Adult Guinea Pigs and Humans

The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus

Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis

Insulin-stimulated Hydrogen Peroxide Reversibly Inhibits Protein-tyrosine Phosphatase 1B in Vivo and Enhances the Early Insulin Action Cascade

Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone-a factorial study

Closing the gap between clinical research and clinical practice: can outcome studies with thiazolidinediones improve our understanding of type 2 diabetes?

Sitagliptin improves glycaemic excursion after a meal or after an oral glucose load in Japanese subjects with impaired glucose tolerance

Effect of initial combination therapy with sitagliptin and metformin on β-cell function in patients with type 2 diabetes

Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes

A comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitus

Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes

A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents

Suchergebnisse filtern